Skin cancer study digs into patient data to spot trends
NCT ID NCT07538960
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks back at the medical records of 350 adults diagnosed with cutaneous T-cell lymphoma, a rare type of skin cancer, treated at Hospital México in Costa Rica between 2019 and 2025. Researchers aim to describe the patients' backgrounds, the treatments they received, and their outcomes. No new treatments are being tested; instead, the goal is to gather information that could help improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital México
San José, Uruca, 10107, Costa Rica
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood test spot lymphoma earlier?
- Two-Drug combo aims to tackle Hard-to-Treat T-Cell lymphoma
- New study aims to decode PTCL by genetic subtype
- Massive T-Cell lymphoma database aims to unlock new insights
- New CAR-T therapy targets tough T-Cell cancers in early trial
- Immunotherapy combo after transplant shows promise for High-Risk blood cancers